Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children. (2nd April 2019)

• Record Type: Journal Article
• Authors: Qian, Maoxiang; Zhao, Xujie; Devidas, Meenakshi; Yang, Wenjian; Gocho, Yoshihiro; Smith, Colton; Gastier-Foster, Julie M; Li, Yizhen; Xu, Heng; Zhang, Shouyue; Jeha, Sima; Zhai, Xiaowen; Sanda, Takaomi; Winter, Stuart S; Dunsmore, Kimberly P; Raetz, Elizabeth A; Carroll, William L; Winick, Naomi J; Rabin, Karen R; Zweidler-Mckay, Patrick A; Wood, Brent; Pui, Ching-Hon; Evans, William E; Hunger, Stephen P; Mullighan, Charles G; Relling, Mary V; Loh, Mignon L; Yang, Jun J
• Is Part Of: Journal of the National Cancer Institute. Volume 111:Number 12(2019)
• Page Start: 1350
• Page End: 1357
• Publication Date: 2019-04-02
• Subjects: Cancer -- Periodicals; Cancer -- Research -- Periodicals; 616.994
• DOI: 10.1093/jnci/djz043
• Languages: English
• ISSNs: 0027-8874

Abstract

Abstract: Background: Acute lymphoblastic leukemia (ALL) is the most common cancer in children and can arise in B or T lymphoid lineages. Although risk loci have been identified for B-ALL, the inherited basis of T-ALL is mostly unknown, with a particular paucity of genome-wide investigation of susceptibility variants in large patient cohorts. Methods: We performed a genome-wide association study (GWAS) in 1191 children with T-ALL and 12 178 controls, with independent replication using 117 cases and 5518 controls. The associations were tested using an additive logistic regression model. Top risk variants were tested for effects on enhancer activity using luciferase assay. All statistical tests were two sided. Results: A novel risk locus in the USP7 gene (rs74010351, odds ratio [OR] = 1.44, 95% confidence interval [CI] = 1.27 to 1.65, P = 4.51 × 10 –8 ) reached genome-wide significance in the discovery cohort, with independent validation (OR = 1.51, 95% CI = 1.03 to 2.22, P = .04). The USP7 risk allele was overrepresented in individuals of African descent, thus contributing to the higher incidence of T-ALL in this race/ethnic group. Genetic changes in USP7 (germline variants or somatic mutations) were observed in 56.4% of T-ALL with TAL1 overexpression, statistically significantly higher than in any other subtypes. Functional analyses suggested this T-ALL risk allele is located in a putative cis -regulatory DNA element with negative effects on USP7 transcription. Finally, comprehensive comparison of 14 susceptibility loci in T- vs B-ALL pointed to distinctive etiology of these leukemias. Conclusions: These findings indicate strong associations between inherited genetic variation and T-ALL susceptibility in children and shed new light on the molecular etiology of ALL, particularly commonalities and differences in the biology of the two major subtypes (B- vs T-ALL).